FDA approves Deciphera’s Romvimza for rare tumour type
Tenosynovial giant cell tumours can cause pain, stiffness, swelling and movement limitations The US Food and Drug Administration (FDA) has...
adminph
Stephan Fritschi
Carbogen Amcis has appointed Stephan Fritschi as CEO Carbogen Amcis has appointed Stephan Fritschi, who is currently serving as the...
UK study highlights importance of GP data in understanding atrial fibrillation
The common heart condition affects approximately 1.5 million people in the UK A new UK study has highlighted the critical...
Brent Shafer
Baxter has appointed Brent Shafer as Chair and Interim CEO Baxter International has appointed Brent Shafer, who has been serving...
NHS England launches first-ever breast cancer screening campaign
New data has shown that around a third of women do not attend screenings after being invited NHS England has...
Heather Knight
Baxter has appointed Heather Knight as Executive Vice President and COO Baxter International has appointed Heather Knight, who has been...
Cambridge scientists develop ‘super test’ for prostate cancer
New test aims to revolutionise prostate cancer screening Scientists in Cambridge have developed a new ‘super test’ for prostate cancer...
Bath researchers awarded Wellcome grant for psychotic disorder study
New funding to investigate cognitive decline and brain ageing The University of Bath has received a £3.5 million Wellcome grant...
An enzyme to disarm tumors
When a tumour develops, it creates a structure around itself called the tumour stroma, within which blood and lymphatic vessels...
Andembry treatment approved across Europe
Significant progress for hereditary angioedema condition Global biotechnology leader CSL has announced that the European Commission (EC) has approved ANDEMBRY...
Illuccix therapy gets approval in the UK
Imaging agent to improve prostate cancer detection Telix Pharmaceuticals has announced that the UK’s Medicines and Healthcare Products Regulatory Agency...
PanK4 identified as a regulator of glucose and lipid metabolism
Physical activity is not only important for fitness, but also for health. This is confirmed by a new study conducted...
Amlenetug receives FDA Fast Track Designation
Potential treatment for multiple system atrophy shows promise Lundbeck’s investigational drug, amlenetug, has been granted Fast Track Designation by the...
Bimekizumab shows long-term efficacy in hidradenitis suppurativa
UCB's BIMZELX reveals promising two-year data at EHSF 2025 UCB has announced impressive two-year data for BIMZELX (bimekizumab) at the...
Why antibiotics can fail even against non-resistant bacteria
Antibiotics are indispensable for treating bacterial infections. But why are they sometimes ineffective, even when the bacteria are not resistant?...
Libtayo available in Scotland for cervical cancer patients
New immunotherapy offers hope for recurrent cervical cancer Regeneron UK Limited has announced that the Scottish Medicines Consortium (SMC) has...
Lynparza approved in Scotland for BRCA-mutated breast cancer patients
Treatment expands options for HER2-negative metastatic breast cancer AstraZeneca announced that its drug Lynparza (olaparib) has been approved for use...
New treatment offers quick cure for common cause of high blood pressure
Doctors at Queen Mary University of London, Barts Health NHS Trust, and University College London have led the development of...
Capgemini unveils AI breakthrough to boost bioeconomy
New methodology may boost innovation in protein engineering Capgemini has introduced a pioneering generative AI-driven methodology for protein engineering, utilising...
Hemgenix shows efficacy among haemophilia B patients
CSL Behring's study reveals significant long-term benefits New data from CSL Behring’s HOPE-B study demonstrates that Hemgenix (etranacogene dezaparvovec-drlb) gene...
